Clinical Trial

A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of BBM-A101 in the Treatment of Knee Osteoarthritis.

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of the study is to evaluate the safety, tolerability, and efficacy of BBM-A101 to treat participants with knee osteoarthritis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-25.
Status change: Not Yet Recruiting → Recruiting 2025-11-16
Trial Details
NCT Number NCT07198555
Lead Sponsor Belief BioMed (Beijing) Co., Ltd
Conditions Knee Osteoarthritis
Enrollment 81 participants
Start Date 2025-10-09
Primary Completion 2027-12-30 (estimated)
Study Completion 2031-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-18